$8.29
5.87% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Stock price

$8.29
+3.60 76.76% 1M
+3.13 60.66% 6M
-4.46 34.98% YTD
-0.54 6.12% 1Y
-9.65 53.79% 3Y
-17.24 67.53% 5Y
-17.24 67.53% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.46 5.87%
ISIN
US89455T1097
Symbol
TMCI
Sector

Key metrics

Market capitalization $516.44m
Enterprise Value $503.76m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.48
P/S ratio (TTM) P/S ratio 2.55
P/B ratio (TTM) P/B ratio 4.92
Revenue growth (TTM) Revenue growth 16.14%
Revenue (TTM) Revenue $202.86m
EBIT (operating result TTM) EBIT $-62.27m
Free Cash Flow (TTM) Free Cash Flow $-43.20m
Cash position $82.80m
EPS (TTM) EPS $-0.99
P/E forward negative
P/S forward 2.49
EV/Sales forward 2.43
Short interest 10.16%
Show more

Is Treace Medical Concepts Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Treace Medical Concepts Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Treace Medical Concepts Inc forecast:

6x Hold
100%

Analyst Opinions

6 Analysts have issued a Treace Medical Concepts Inc forecast:

Hold
100%

Financial data from Treace Medical Concepts Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
203 203
16% 16%
100%
- Direct Costs 39 39
18% 18%
19%
164 164
16% 16%
81%
- Selling and Administrative Expenses 198 198
18% 18%
98%
- Research and Development Expense 20 20
30% 30%
10%
-54 -54
30% 30%
-27%
- Depreciation and Amortization 7.95 7.95
27% 27%
4%
EBIT (Operating Income) EBIT -62 -62
29% 29%
-31%
Net Profit -62 -62
29% 29%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Treace Medical Concepts Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Treace Medical Concepts Inc Stock News

Neutral
GlobeNewsWire
8 days ago
PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ®  and Adductoplasty ®  Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. ...
Neutral
Seeking Alpha
20 days ago
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2024 Earnings Call November 5, 2024 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer Mark Hair - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Danielle Antalffy - UBS Operator Good day and thank you for standing by. Welcome to the Treace Medical Concepts Thi...
Neutral
GlobeNewsWire
20 days ago
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ:TMCI) on behalf of Treace stockholders. Our investigation concerns whether Treace has violated the federal securities laws and/or engaged in other unlawful busines...
More Treace Medical Concepts Inc News

Company Profile

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Head office United States
CEO John Treace
Employees 516
Founded 2013
Website www.treace.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today